Get started
Author

Caroline Berg Venemyr

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
2022 · Livio Pagano, Jon Salmanton-García, et al. · Blood · 91
PDF
Outcome of infection with omicron SARS‐CoV ‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
2022 · Ola Blennow, Jon Salmanton‐García, et al. · American Journal of Hematology · 74
PDF
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
2023 · Alessandro Busca, Jon Salmanton-García, et al. · Frontiers in Immunology · 38
PDF
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
2024 · Jon Salmanton-García, Francesco Marchesi, et al. · EClinicalMedicine · 35
PDF
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
2022 · Jon Salmanton-García, Francesco Marchesi, et al. · HemaSphere · 35
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey
2022 · Chiara Cattaneo, Jon Salmanton-García, et al. · Cancers · 9
PDF
P1521: Improved Clinical Outcome of Covid-19 in Haematologic Malignancy Patients Receiving a Fourth Dose of Anti-sars-cov-2 Vaccine: an Epicovideha Report
2023 · Jon Salmanton-García, Francesco Marchesi, et al. · HemaSphere
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey
2022 · Pagano, Livio, Salmanton-García, Jon, et al. · Kölner Universitäts PublikationsServer (Universität zu Köln)
PDF
Works count: 8
Citation count: 282
H-index: 6
I10-index: 5
Year
Topic
Type